{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T12:43:50Z","timestamp":1772369030433,"version":"3.50.1"},"reference-count":35,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1097\/pas.0b013e318282da7f","type":"journal-article","created":{"date-parts":[[2013,5,4]],"date-time":"2013-05-04T13:55:22Z","timestamp":1367675722000},"page":"1123-1130","source":"Crossref","is-referenced-by-count":52,"title":["Fallopian Tube Intraluminal Tumor Spread From Noninvasive Precursor Lesions"],"prefix":"10.1097","volume":"37","author":[{"given":"Jonathan G.","family":"Bijron","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelis A.","family":"Seldenrijk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald P.","family":"Zweemer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joost G.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ren\u00e9 H.M.","family":"Verheijen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul J.","family":"van Diest","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-1-20210131","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1006\/gyno.1999.5623","article-title":".Molecular evidence linking primary cancer of the fallopian tube to BRCA1 germline mutations.","volume":"76","author":"Zweemer","year":"2000","journal-title":"Gynecol Oncol"},{"key":"R2-1-20210131","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":".Dysplastic changes in prophylactically removed fallopian tubes of women predisposed to developing ovarian cancer.","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"R3-1-20210131","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1097\/00000478-200110000-00009","article-title":".Occult carcinoma in prophylactic oophorectomy specimens: prevalence and association with BRCA germline mutation status.","volume":"25","author":"Colgan","year":"2001","journal-title":"Am J Surg Pathol"},{"key":"R4-1-20210131","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1006\/gyno.2002.6779","article-title":".Pathologic findings in prophylactic oophorectomy specimens in high-risk women.","volume":"87","author":"Leeper","year":"2002","journal-title":"Gynecol Oncol"},{"key":"R5-1-20210131","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1200\/JCO.2005.04.109","article-title":".Risk-reducing salpingo-oophorectomy in BRCA mutation carriers: role of serial sectioning in the detection of occult malignancy.","volume":"23","author":"Powell","year":"2005","journal-title":"J Clin Oncol"},{"key":"R6-1-20210131","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.ygyno.2005.06.065","article-title":".Clinical and pathologic findings of prophylactic salpingo-oophorectomies in 159 BRCA1 and BRCA2 carriers.","volume":"100","author":"Finch","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R7-1-20210131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1046\/j.1365-2559.2003.01654.x","article-title":".Expression of differentiation and proliferation related proteins in epithelium of prophylactically removed ovaries from women with a hereditary female adnexal cancer predisposition.","volume":"43","author":"Piek","year":"2003","journal-title":"Histopathology"},{"key":"R8-1-20210131","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0140-6736(01)05992-X","article-title":".Tubal ligation and risk of ovarian cancer.","volume":"358","author":"Piek","year":"2001","journal-title":"Lancet"},{"key":"R9-1-20210131","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S0090-8258(03)00365-2","article-title":".BRCA12-related ovarian cancers are of tubal origin: a hypothesis.","volume":"90","author":"Piek","year":"2003","journal-title":"Gynecol Oncol"},{"key":"R10-1-20210131","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.ygyno.2007.07.007","article-title":".Ovarian carcinogenesis, an alternative theory.","volume":"107","author":"Piek","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R11-1-20210131","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1200\/JCO.2007.12.2622","article-title":".Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction.","volume":"25","author":"Callahan","year":"2007","journal-title":"J Clin Oncol"},{"key":"R12-1-20210131","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/01.pas.0000213335.40358.47","article-title":".Intraepithelial carcinoma of the fimbria and pelvic serous carcinoma: Evidence for a causal relationship.","volume":"31","author":"Kindelberger","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"R13-1-20210131","first-page":"1407","article-title":"Ronnett BM, et al..","volume":"34","author":"Przybyci","year":"2010","journal-title":"Are all pelvic (nonuterine) serous carcinomas of tubal originAm J Surg Pathol"},{"key":"R14-1-20210131","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1200\/JCO.2008.16.4814","article-title":".Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention.","volume":"26","author":"Carlson","year":"2008","journal-title":"J Clin Oncol"},{"key":"R15-1-20210131","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":".The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin.","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"R16-1-20210131","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1002\/path.2091","article-title":".A candidate precursor to serous carcinoma that originates in the distal fallopian tube.","volume":"211","author":"Lee","year":"2007","journal-title":"J Pathol"},{"key":"R17-1-20210131","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/path.2739","article-title":".Secretory cell outgrowth, PAX2 and serous carcinogenesis in the fallopian tube.","volume":"222","author":"Chen","year":"2010","journal-title":"J Pathol"},{"key":"R18-1-20210131","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1038\/modpathol.2011.175","article-title":".PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer.","volume":"25","author":"Quick","year":"2012","journal-title":"Mod Pathol"},{"key":"R20-1-20210131","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/01.pas.0000180854.28831.77","article-title":".The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome.","volume":"30","author":"Medeiros","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"R21-1-20210131","doi-asserted-by":"crossref","first-page":"4376","DOI":"10.1091\/mbc.e03-05-0279","article-title":".Gene expression patterns in ovarian carcinomas.","volume":"14","author":"Schaner","year":"2003","journal-title":"Mol Biol Cell"},{"key":"R22-1-20210131","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ygyno.2006.08.052","article-title":".Emerging roles for PAX8 in ovarian cancer and endosalpingeal development.","volume":"104","author":"Bowen","year":"2007","journal-title":"Gynecol Oncol"},{"key":"R23-1-20210131","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":".A comprehensive analysis of PAX8 expression in human epithelial tumors.","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R24-1-20210131","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/ERC-11-0338","article-title":".Promoter hypermethylation patterns in fallopian tube epithelium of BRCA1 and BRCA2 germ line mutation carriers.","volume":"19","author":"Bijron","year":"2012","journal-title":"Endocr Relat Cancer"},{"key":"R26-1-20210131","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1002\/path.2696","article-title":".Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary.","volume":"221","author":"Ahmed","year":"2010","journal-title":"J Pathol"},{"key":"R27-1-20210131","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1097\/PAS.0b013e31822f58bc","article-title":".Diagnosis of serous tubal intraepithelial carcinoma based on morphologic and immunohistochemical features: a reproducibility study.","volume":"35","author":"Visvanathan","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"R30-1-20210131","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1097\/PAS.0b013e3181cf3d79","article-title":"Shih IeM.The origin and pathogenesis of epithelial ovarian cancer: a proposed unifying theory.","volume":"34","author":"Kurman","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"R31-1-20210131","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1097\/00000478-200006000-00004","article-title":".Minimal uterine serous carcinoma: diagnosis and clinicopathologic correlation.","volume":"24","author":"Wheeler","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"R32-1-20210131","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1006\/gyno.2000.6071","article-title":".Occult cancer of the fallopian tube in BRCA-1 germline mutation carriers at prophylactic oophorectomy: a case for recommending hysterectomy at surgical prophylaxis.","volume":"80","author":"Paley","year":"2001","journal-title":"Gynecol Oncol"},{"key":"R33-1-20210131","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00000478-200202000-00003","article-title":".Unexpected gynecologic neoplasms in patients with proven or suspected BRCA-1 or -2 mutations: implications for gross examination, cytology, and clinical follow-up.","volume":"26","author":"Agoff","year":"2002","journal-title":"Am J Surg Pathol"},{"key":"R34-1-20210131","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1097\/01.pas.0000131554.05732.cd","article-title":".Follow-up of in situ and early-stage fallopian tube carcinoma in patients undergoing prophylactic surgery for proven or suspected BRCA-1 or BRCA-2 mutations.","volume":"28","author":"Agoff","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R35-1-20210131","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1525-1438.2007.01039.x","article-title":"2nd, et al..Assessment of TP53 mutation using purified tissue samples of ovarian serous carcinomas reveals a higher mutation rate than previously reported and does not correlate with drug resistance.","volume":"18","author":"Salani","year":"2008","journal-title":"Int J Gynecol Cancer"},{"key":"R36-1-20210131","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2005.01.024","article-title":".Outcome of surveillance and prophylactic salpingo-oophorectomy in asymptomatic women at high risk for ovarian cancer.","volume":"97","author":"Meeuwissen","year":"2005","journal-title":"Gynecol Oncol"},{"key":"R38-1-20210131","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ygyno.2005.08.038","article-title":".CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer.","volume":"100","author":"Olivier","year":"2006","journal-title":"Gynecol Oncol"},{"key":"R39-1-20210131","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1038\/sj.bjc.6603015","article-title":".Surveillance of women at high risk for hereditary ovarian cancer is inefficient.","volume":"94","author":"Oei","year":"2006","journal-title":"Br J Cancer"},{"key":"R40-1-20210131","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1038\/sj.bjc.6603725","article-title":".No efficacy of annual gynaecological screening in BRCA12 mutation carriers; an observational follow-up study.","volume":"96","author":"Hermsen","year":"2007","journal-title":"Br J Cancer"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0b013e318282da7f","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:58:10Z","timestamp":1620968290000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201308000-00001"}},"subtitle":["A Novel Metastatic Route in Early Pelvic Carcinogenesis"],"short-title":[],"issued":{"date-parts":[[2013,8]]},"references-count":35,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0b013e318282da7f","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2013,8]]}}}